GTAT News 14.91 07/28/2014 05:17:17 Gt Advanced Technologies

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gt Advanced Technologies Inc (GTAT) 14.91 $GTAT

Critical Alerts For GT Advanced Technologies, Tesla Motors, Delta Airlines, Cree, and Lululemon Released By InvestorsObserver
PR Newswire - Thu Jul 24, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for GTAT, TSLA, DAL, CREE, and LULU.

GT Advanced Technologies to Host Q2FY14 Conference Call and Webcast on August 5, 2014
GlobeNewswire - Tue Jul 22, 3:11PM CDT
GT Advanced Technologies, Inc. (Nasdaq:GTAT) today announced that the company will release its financial results for the quarter ending June 28, 2014 after the market closes on NASDAQ on Monday, August 4, 2014. Management will conduct an investment community conference call the following day, Tuesday, August 5, 2014, at 8:00am ET. The call will be available on a live and archived basis as follows:

GT Advanced Technologies Analyst Report; The Future Isn't Quite Crystal Clear by BrokerBank Securities, Inc.
PR Newswire - Mon Jul 21, 7:00AM CDT
GT Advanced Technology (NASDAQ: GTAT) The markets for LEDs, smart phones, and solar panels are all multi-billion dollar opportunities with accelerating growth. Each of these markets is driving demand for specialized crystals such as polysilicon, photovoltaic, and sapphire crystals. Polysilicon is a material consisting of small silicon crystals, and is used in the manufacture of semiconductors, solar cells, and other thin-film devices. Photovoltaics is a method of generating electrical power by converting solar radiation into electricity using semiconductors. Sapphire crystals are the second hardest substance known to man, and are used in dental, medical device, specialty optical applications, and watch crystals.

Apple Supply Cuts Are Killing GT Advanced, but Solar Potential Makes It a Long-Term Buy
Jason Hall, The Motley Fool - Motley Fool - Sun Jul 20, 12:10PM CDT
When GT Advanced Technologies '   transformative deal with  Apple     last year was a culmination of a promise from CEO Tom Gutierrez that its sapphire would be a transformative business and product. While the company's legacy is in the solar...

Apple, Inc.'s iPhone 6 Display: Nearly Indestructible?
Daniel Sparks, The Motley Fool - Motley Fool - Sun Jul 20, 8:00AM CDT
The speculation is building. Apple 's upcoming iPhone 6 almost certainly looks poised to sport this wild new technology. With the company's newly forged partnership with sapphire crystal maker GT Advanced Technologies it's rumored that Apple is...

Here’s What We Know About the iPhone 6 So Far
Ashraf Eassa, The Motley Fool - Motley Fool - Sat Jul 19, 11:05AM CDT
The launch date of Apple 's next generation iPhone -- known for now as the iPhone 6 -- appears to be fast approaching. While the exact launch date is unknown to all but to a chosen few, it's probably safe to bank on a mid-September launch....

What Makes GT Advanced Technologies (GTAT) a Strong Sell? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 17, 7:38AM CDT
GT Advanced Technologies has seen negative earnings estimate revisions for the current year along with a significant decline in its share price for the past month

Nasdaq stocks posting largest percentage decreases
AP - Tue Jul 15, 12:20PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:

Most active Nasdaq-traded stocks
AP - Tue Jul 15, 12:20PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:

'Fast Money' Recap: Will Apple's Next Phone Be Delayed?
at The Street - Tue Jul 15, 4:00AM CDT
The trading panel discussed the iPhone 6, bank stocks and Alibaba.

Could This Be the Best Growth Stock of the Next Decade?
Adam Galas, The Motley Fool - Motley Fool - Mon Jul 14, 8:00PM CDT
GT Advanced Technologies is one of Wall Street's hottest stocks since Apple   picked the company to manufacture sapphire for some of its upcoming products. Source:  GTAT data by YCharts In the last year, the company has almost...

SmarTrend Watching for Potential Rebound in Shares of GT Advanced Technologies After 4.92% Loss
Comtex SmarTrend(R) - Mon Jul 14, 4:09PM CDT
GT Advanced Technologies (NASDAQ:GTAT) traded in a range yesterday that spanned from a low of $15.05 to a high of $15.59. Yesterday, the shares fell 4.9%, which took the trading range below the 3-day low of $15.60 on volume of 19.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

3 Huge Stocks on Traders' Radars
at The Street - Mon Jul 14, 1:42PM CDT
Here's how to trade some of the most active stocks on the market today.

EBay and Sotheby's Team Up: Tech Winners & Losers
at The Street - Mon Jul 14, 12:16PM CDT
GT Advanced Technologies shares fell on an analyst report, while Apple shares rose on on analyst upgrade.

Why GT Advanced Technologies (GTAT) Stock Is Dropping Today
at The Street - Mon Jul 14, 10:15AM CDT
GT Advanced Technologies (GTAT) shares are down after analysts at CLSA lowered its revenue and EPS guidance for this year and next.

3 Tech Stocks That Crashed This Week
Anders Bylund, The Motley Fool - Motley Fool - Sun Jul 13, 8:00PM CDT
Source: GT Advanced Technologies. The tech-heavy Nasdaq Composite index had a rough week between July 7 and July 11. The index fell 1.6%, well below the milder 0.9% drop of the broad-market indicator S&P 500 . But these three tech...

5 of Last Week's Biggest Losers
Rick Munarriz, The Motley Fool - Motley Fool - Sun Jul 13, 12:00PM CDT
There's never a shortage of stocks going the wrong way in any given chunk of time. No stock goes straight up, and sometimes fundamentals can get a bit wobbly. Let's take a closer look at five of this past week's biggest sinkers. Company ...

Why Apple Inc.'s Shift to Sapphire In the iPhone 6 Will Be Brilliant -- and Perfectly Timed
Evan Niu, CFA, The Motley Fool - Motley Fool - Sun Jul 13, 11:00AM CDT
Source: GT Advanced.  At this point, there should be little doubt left that Apple will transition from Corning Gorilla Glass to sapphire in both upcoming iPhone 6 models. Despite Apple's desire for secrecy, some of its bigger moves of late...

'Mad Money' Lightning Round: American Airlines Delivers
at The Street - Fri Jul 11, 5:00AM CDT
Cramer is avoiding Annaly Capital, warns GW Pharmaceuticals could have ups and down and likes Ensco over Transocean.

Jim Cramer's 'Mad Money' Recap: Buy, Don't Sell, on European Weakness
at The Street - Thu Jul 10, 7:02PM CDT
It's not 2008 anymore and one Portugal bank's problems is no reason to panic, Cramer says.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 170

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 358

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 336

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 364

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 86

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 372

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 64

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Trump's Executive Orders and Their Economic Impact

Updated Category News Views 806

Executive Orders: A Shift in Economic Paradigms President Trump has taken significant steps by issuing a number of executive orders that have raised eyebrows among economists and market analysts alike. According to market expert Louis Navellier, this approach can be characterized as 'shock and awe'. It reflects a bold strategy that could reshape various aspects of the...

Continue Reading
B2PRIME Expands Institutional Reach with Stuart Brock's Addition

Updated Category News Views 173

B2PRIME Welcomes Stuart Brock as Institutional Business Development Manager B2PRIME Group, a leading financial services provider for institutional and professional clients, recently announced the appointment of Stuart Brock as its Institutional Business Development Manager. With over 15 years of experience in electronic trading and institutional sales, Stuart is poised to...

Continue Reading
United Parks & Resorts Inc. Shares Q1 2025 Financial Insights

Updated Category News Views 374

Financial Overview of United Parks & Resorts Inc. United Parks & Resorts Inc. (NYSE: PRKS), a prominent player in the theme park and entertainment sector, has recently shared its financial results for the first quarter of 2025. This report delves into the key metrics and operational insights that define the company’s performance in this period. Attendance and Revenue...

Continue Reading
Seongnam Pavilion Sets New Benchmark at CES 2025 with 41 Companies

Updated Category News Views 178

Seongnam Pavilion Makes Waves at CES 2025 At the latest CES 2025, Seongnam City showcased an impressive turnout at the world's leading consumer electronics exhibition. This year, Seongnam participated with a remarkable delegation of 41 companies, marking the largest participation ever. Focused on enhancing their global footprint, these small and medium-sized enterprises...

Continue Reading
Gaucho Holdings Seizes Opportunities Amid Argentina's Economic Revival

Updated Category News Views 179

Gaucho Holdings and the New Economic Landscape in Argentina Recently, Argentina has entered a new chapter of economic transformation. A shift in leadership, with Javier Milei becoming president, has sparked hopes for fiscal discipline, growth, and development. As the country embraces pro-market reforms, Gaucho Group Holdings, Inc. (NASDAQ: VINO) positions itself to...

Continue Reading